BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Slotta JE, Kollmar O, Ellenrieder V, Ghadimi BM, Homayounfar K. Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives. World J Hepatol 2015; 7(9): 1168-1183 [PMID: 26019733 DOI: 10.4254/wjh.v7.i9.1168]
URL: https://www.wjgnet.com/1007-9327/full/v7/i9/1168.htm
Number Citing Articles
1
Xiao-Bo Lai, Yu-Qiang Nie, Hong-Li Huang, Ying-Fei Li, Chuang-Yu Cao, Hui Yang, Bo Shen, Zhi-Qiang Feng. NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferationOncology Letters 2017; 13(3): 1587 doi: 10.3892/ol.2017.5618
2
Heng Wu, Junyan Tao, Xiaolei Li, Tianpeng Zhang, Lei Zhao, Yao Wang, Lei Zhang, Jun Xiong, Zhi Zeng, Na Zhan, Clifford J. Steer, Li Che, Mingjie Dong, Xiaomei Wang, Junqi Niu, Zhuoyu Li, Guiqing Yan, Xin Chen, Guisheng Song. MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in miceHepatology 2017; 66(6): 1952 doi: 10.1002/hep.29374
3
Jendrik Becker-Assmann, Mohammad H. Fard-Aghaie, Alexandros Kantas, Georgios Makridis, Tim Reese, Kim C. Wagner, Jörg Petersen, Peter Buggisch, Axel Stang, Thomas von Hahn, Karl J. Oldhafer. Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären KarzinomDer Chirurg 2020; 91(9): 769 doi: 10.1007/s00104-020-01118-6
4
Bashan Zhang, Fei Li, Zinian Zhu, Aijiao Ding, Jintong Luo. <p>CircRNA CDR1as/miR-1287/Raf1 Axis Modulates Hepatocellular Carcinoma Progression Through MEK/ERK Pathway</p>Cancer Management and Research 2020; : 8951 doi: 10.2147/CMAR.S252679
5
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Agustín F. González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A. Barrera. High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantationExpert Review of Molecular Diagnostics 2019; 19(7): 635 doi: 10.1080/14737159.2019.1619549
6
Mattia Garancini, Enrico Pinotti, Stefano Nespoli, Fabrizio Romano, Luca Gianotti, Vittorio Giardini. Hepatic resection beyond barcelona clinic liver cancer indication: When and howWorld Journal of Hepatology 2016; 8(11): 513-519 doi: 10.4254/wjh.v8.i11.513
7
ZHICHENG YAO, KUNPENG HU, HE HUANG, SHILEI XU, QINGLIANG WANG, PENG ZHANG, PEISHENG YANG, BO LIU. shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferationInternational Journal of Molecular Medicine 2015; 36(5): 1393 doi: 10.3892/ijmm.2015.2350
8
Xinyan Chen, Xianxian Hu, Junjie Hu, Zhenpeng Qiu, Ming Yuan, Guohua Zheng. Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT/c-Met-Triggered Rapid Hepatocarcinogenesis in MiceMolecular Pharmaceutics 2020; 17(3): 738 doi: 10.1021/acs.molpharmaceut.9b00428
9
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Pedro Abreu-González, Dácil Díaz, Antonia Moreno, Elisa Borja, María Martín, Alejandro Jiménez, Manuel Barrera. Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2016; 17(4): 500 doi: 10.3390/ijms17040500
10
Shengyan Xi, Ying Peng, Gerald Y. Minuk, Mengmeng Shi, Biqian Fu, Jiaqi Yang, Qian Li, Yuewen Gong, Lifeng Yue, Lili Li, Jinhua Guo, Yang Peng, Yanhui Wang. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapyJournal of Ethnopharmacology 2016; 190: 1 doi: 10.1016/j.jep.2016.05.055
11
Antonio Giorgio, Maria G Merola, Luca Montesarchio, Francesca Merola, Pietro Gatti, Carmine Coppola, Valentina Giorgio, Giorgio Calisti. Percutaneous radiofrequency ablation of hepatocellular carcinoma in cirrhosis: analysis of complications in a single centre over 20 yearsThe British Journal of Radiology 2017; 90(1074): 20160804 doi: 10.1259/bjr.20160804
12
Chang Liu, Xiaoxia Zhu, Yuqi Jia, Fenqing Chi, Keru Qin, Jinhong Pei, Chan Zhang, Xiuli Mu, Hongwei Zhang, Xiushan Dong, Jun Xu, Baofeng Yu. Dasatinib inhibits proliferation of liver cancer cells, but activation of Akt/mTOR compromises dasatinib as a cancer drugActa Biochimica et Biophysica Sinica 2021; 53(7): 823 doi: 10.1093/abbs/gmab061
13
A. Bauschke, A. Altendorf-Hofmann, C. Malessa, S. Schüle, J. Zanow, U. Settmacher. Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV?Journal of Cancer Research and Clinical Oncology 2016; 142(12): 2593 doi: 10.1007/s00432-016-2260-y
14
Michihiro Kudou, Atsushi Shiozaki, Toshiyuki Kosuga, Hiroki Shimizu, Daisuke Ichikawa, Hirotaka Konishi, Ryo Morimura, Shuhei Komatsu, Hisashi Ikoma, Hitoshi Fujiwara, Kazuma Okamoto, Yoshinori Marunaka, Eigo Otsuji. Heat shock exerts anticancer effects on liver cancer via autophagic degradation of aquaporin 5International Journal of Oncology 2017; 50(5): 1857 doi: 10.3892/ijo.2017.3940
15
Hyosun Tak, Hoin Kang, Eunbyul Ji, Youlim Hong, Wook Kim, Eun Kyung Lee. Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinomaBiochemical and Biophysical Research Communications 2018; 497(4): 1117 doi: 10.1016/j.bbrc.2018.02.189
16
Zaixiong Ji, Jiaqi Li, Jianbo Wang. Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinomaHereditas 2021; 158(1) doi: 10.1186/s41065-021-00179-9
17
Yanxia Gong, Jie Zhang, Xiang Wu, Tao Wang, Jia Zhao, Zhi Yao, Qingyu Zhang, Xi Liu, Xu Jian. Specific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapyOncology Letters 2017; 14(4): 4158 doi: 10.3892/ol.2017.6724
18
Jixiong Hu, Weidong Dai, Chun Liu, Tenglong Tang. Atlas of Anatomic Hepatic Resection for Hepatocellular Carcinoma2019; : 261 doi: 10.1007/978-981-13-0668-6_5
19
Leonardo Lorente. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(37): 4230-4242 doi: 10.3748/wjg.v24.i37.4230
20
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Pedro Abreu-González, Agustín González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel Barrera. Low Serum Melatonin Levels Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma are Associated with Lower Survival after Liver TransplantationInternational Journal of Molecular Sciences 2019; 20(7): 1696 doi: 10.3390/ijms20071696
21
Tonghai Xing, Tingmang Yan, Qiang Zhou. Identification of key candidate genes and pathways in hepatocellular carcinoma by integrated bioinformatical analysisExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6075
22
Sebastian Lünse, Claus-Dieter Heidecke, Lars Ivo Partecke. Hepatocellular Carcinoma2019; : 111 doi: 10.15586/hepatocellularcarcinoma.2019.ch6
23
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059